Clinical follow-up of 411 relapsing and progressive patients with multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real-life cohort study.
Fiche publication
Date publication
juillet 2018
Journal
European journal of neurology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Chartier N, Epstein J, Soudant M, Dahan C, Michaud M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Mathey G
Lien Pubmed
Résumé
Mitoxantrone has been used to treat patients with aggressive multiple sclerosis (MS) for decades. We aimed to describe the effectiveness and adverse events over 10 years post-mitoxantrone in relapsing and progressive MS patients from an exhaustive real-life database.
Mots clés
long term, mitoxantrone, multiple sclerosis, observational study, safety, therapeutic
Référence
Eur. J. Neurol.. 2018 Jul 11;: